CYP2D6 Genotype and Tamoxifen Response for Breast Cancer: A Systematic Review and Meta-Analysis
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference58 articles.
1. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010;R Lozano;Lancet,2012
2. Cancer survival in five continents: a worldwide population-based study (CONCORD);MP Coleman;Lancet Oncol,2008
3. Tamoxifen Background Summary;U.S. FDA,2006
4. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial;J Cuzick;Lancet Oncol,2011
5. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;C Davies;Lancet,2011
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Interplay between Pharmacokinetics and Pharmacogenomics;Dosage Forms - Innovation and Future Perspectives;2023-04-05
2. Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy;Cancers;2022-11-04
3. Pharmacogenetic testing-guided treatment for oncology: an overview of reviews;Pharmacogenomics;2022-08
4. Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy;Cancers;2021-02-12
5. DNA derived from archival tumor specimens can be used for germline pharmacogenetic analyses;Pharmacogenomics;2020-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3